NCT02757261

Brief Summary

Bruxism is a repetitive activity of the masticatory muscles characterized by grinding and/or clenching one's teeth or parafunctional movements of the mandible. The aim of the proposed controlled clinical trial is to evaluate muscle activity, bite force and salivary cortisol in children aged six to eight years with bruxism. The children will be randomly allocated to four groups, each with 19 participants: Group 1 will receive low-level laser therapy at acupuncture points; Group 2 will use an occlusal splint; Group 3 will receive placebo laser therapy; and Group 4 will be the control group without bruxism. Low-level laser (786.94 nm, 0.04 cm2, 70 mW and 20 s per points) will be applied directly on the skin at six acupuncture points on each side. The BTS TMJOINT electromyograph will be used to determine muscle activity and a digital gnathodynamometer will be used to measure bite force. Two saliva collections will be performed in the participant's home at 9 am and prior to going to sleep, with at least one hour of fasting and followed by oral hygiene with water. Evaluations will be performed before as well as one and six months after treatment. The findings will be computed and submitted to statistical analysis. Descriptive statistics will be used first for the determination of point estimates, precision and validation using analysis of variance (ANOVA) for the evaluation of residuals and parametric tests will be used for the determination of pre-treatment conditions. Interval estimates will be used for the variables of interest to determine the prevision of the estimates and perform comparisons. When necessary, transformation methods or non-parametric tests will be used in the data analysis. The chi-square test, Student's t-test and ANOVA will be employed, with the level of significance set at 5% (p \< 0.05).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
76

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jun 2016

Shorter than P25 for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2016

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 2, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

May 2, 2016

Status Verified

April 1, 2016

Enrollment Period

4 months

First QC Date

April 8, 2016

Last Update Submit

April 27, 2016

Conditions

Keywords

BruxismChildOcclusal splintBite forceAcunpunctureLaserMuscle actvitySalivary Cortisol

Outcome Measures

Primary Outcomes (3)

  • Change in ELECTROMYOGRAPHIC EVALUATION OF MASTICATORY AND TRAPEZIUS MUSCLES

    six-channel BTS TMJOINT electromyograph (BTS Engineering)

    Before and after treatment and follow up 1 month and 6 months

  • Change in Bite force

    Bite force will be measured using a digital gnathodynamometer (DMD, Kratos Equipamentos Industriais Ltda, Cotia, São Paulo, Brazil) adapted for oral conditions

    Before and after treatment and follow up 1 month and 6 months

  • Change in Salivary cortisol

    Saliva will be collected on cotton swabs, which will be left in the mouth for two minutes. The cotton will then be placed into a centrifuge tube and the sample will be stored at -20° C until analysis.25 Salivary cortisol will be measured prior to therapy and on Day 50 to measure the degree of stress. Two collections will be performed in the home of the participant at 9 am and prior to going to sleep with at least one hour of fasting prior to the collection and will be followed with oral hygiene with water. The collection will be performed on a Sunday following the manufacturer's recommendations and will be delivered on the following Monday for analysis at University Nove de Julho (Brazil).

    Before and after treatment and follow up 1 month and 6 months

Study Arms (4)

Application of Low-level laser therapy.

EXPERIMENTAL

The intervention will be twelve sessions (two per week). Laser parameters: wavelength - 786.94 nm; conventional tip; energy density - 25 J/cm²; intensity - 1.675 mW/cm²; output power - 70 mW (0.070 W); and exposure time - 20 seconds per point. The point application method will be used with direct contact with the skin (spot beam of 0.04 cm²), following the protocol suggested by Carvalho et al.50 and Venezian et al.44 A potentiometer will be used to determine the mean power of the laser equipment to ensure the safety of the operator.

Device: Laser

Treatment with Occlusal splint.

EXPERIMENTAL

The intervention will be a maxillary occlusal splint will be used on the maxilla with palatal and occlusal coverage. Following the protocol established by Hachmann et al., the children will only use the splint at night for two months, with weekly adjustments of a quarter turn.46

Device: Occlusal splint

Placebo laser

ACTIVE COMPARATOR

Placebo laser will be performed using the same equipment.

Device: Placebo laser

Children without bruxism

NO INTERVENTION

Control group

Interventions

LaserDEVICE

Low-level laser therapy administrated to acupoints

Application of Low-level laser therapy.

Occlusal splint with expander

Treatment with Occlusal splint.

Placebo laser (Low-level laser therapy administrated to acupoints)

Placebo laser

Eligibility Criteria

Age6 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Male and female children
  • Aged six to eight years
  • No physical or psychiatric limitations
  • Need to have the first molars in Angle Class I
  • Free of dental caries
  • A clinical examination of tooth wear and the reports of parents/caregivers regarding tooth clenching/grinding will be used for the diagnosis of bruxism, following the criteria established by the American Academy of Sleep Medicine1 and the use of a questionnaire adapted by Serra Negra (2014).

You may not qualify if:

  • Use of muscle relaxants
  • Temporomandibular disorder
  • Currently undergoing another treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Salgueiro MDCC, Bortoletto CC, Horliana ACR, Mota ACC, Motta LJ, Motta PB, MesquitaFerrari RA, Fernandes KPS, Bussadori SK. Evaluation of muscle activity, bite force and salivary cortisol in children with bruxism before and after low level laser applied to acupoints: study protocol for a randomised controlled trial. BMC Complement Altern Med. 2017 Aug 8;17(1):391. doi: 10.1186/s12906-017-1905-y.

MeSH Terms

Conditions

Sleep BruxismBruxism

Interventions

LasersOcclusal Splints

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesParasomniasSleep Wake DisordersNervous System DiseasesMental DisordersHabitsBehavior

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and SuppliesRadiation Equipment and SuppliesOrthotic DevicesOrthopedic EquipmentSurgical Equipment

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Monica Canuto Salgueiro

Study Record Dates

First Submitted

April 8, 2016

First Posted

May 2, 2016

Study Start

June 1, 2016

Primary Completion

October 1, 2016

Study Completion

March 1, 2017

Last Updated

May 2, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share